Close Menu

Todd Nelson

SGI-DNA has appointed Todd Nelson as CEO to lead its spin out from Synthetic Genomics. Nelson has led several life sciences companies through phases of financial and commercial growth, including eBioscience (which was acquired by Affymetrix), MP Biomedicals (which was acquired by Valeant Fine Chemicals), and DiscoverX Corporation (now Eurofins), SGI-DNA said. He is also the founder of Tonbo Biosciences and TCRx Corporation.


Armin Winands and Jan Hellemans

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Newsweek discusses the privacy issues raised by digital medicine.

A group of statisticians wants to eliminate researchers' reliance on 'statistical significance,' according to NPR.

In Nature this week: genetic analysis of Anatolian farmers, cotton genome analysis, and more.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.